AU2008334075A1 - Tetrahydro-isoquinoline PPAT inhibitors as antibacterial agents - Google Patents
Tetrahydro-isoquinoline PPAT inhibitors as antibacterial agents Download PDFInfo
- Publication number
- AU2008334075A1 AU2008334075A1 AU2008334075A AU2008334075A AU2008334075A1 AU 2008334075 A1 AU2008334075 A1 AU 2008334075A1 AU 2008334075 A AU2008334075 A AU 2008334075A AU 2008334075 A AU2008334075 A AU 2008334075A AU 2008334075 A1 AU2008334075 A1 AU 2008334075A1
- Authority
- AU
- Australia
- Prior art keywords
- independently
- alkyl
- compound
- aryl
- aralkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99152507P | 2007-11-30 | 2007-11-30 | |
US60/991,525 | 2007-11-30 | ||
PCT/US2008/084948 WO2009073545A2 (fr) | 2007-11-30 | 2008-11-26 | Inhibiteurs tétrahydro-isoquinolino de ppat utilisés en tant qu'agents antibactériens |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2008334075A1 true AU2008334075A1 (en) | 2009-06-11 |
Family
ID=40718459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2008334075A Abandoned AU2008334075A1 (en) | 2007-11-30 | 2008-11-26 | Tetrahydro-isoquinoline PPAT inhibitors as antibacterial agents |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2225207A2 (fr) |
JP (1) | JP2011518109A (fr) |
CN (1) | CN102007101A (fr) |
AU (1) | AU2008334075A1 (fr) |
CA (1) | CA2707445A1 (fr) |
WO (1) | WO2009073545A2 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8124616B2 (en) | 2007-11-30 | 2012-02-28 | Biota Scientific Management Pty Ltd | Bicyclic PPAT inhibitors as antibacterial agents |
FR2986002B1 (fr) | 2012-01-24 | 2014-02-21 | Servier Lab | Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
CN102603755B (zh) * | 2012-02-08 | 2015-09-09 | 中国人民解放军第二军医大学 | 一类具有协同氟康唑抗耐药真菌作用的化合物 |
FR3008975A1 (fr) | 2013-07-23 | 2015-01-30 | Servier Lab | Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR3008977A1 (fr) | 2013-07-23 | 2015-01-30 | Servier Lab | Nouveaux derives d'isoindoline ou d'isoquinoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR3008976A1 (fr) | 2013-07-23 | 2015-01-30 | Servier Lab | "nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent" |
EP3183248B1 (fr) | 2014-08-21 | 2020-11-11 | Bristol-Myers Squibb Company | Dérivés rattachés de benzamide utilisés comme puissants inhibiteurs de rock |
JP6840727B2 (ja) * | 2015-08-12 | 2021-03-10 | シンジェンタ パーティシペーションズ アーゲー | 殺微生物二環式複素環式誘導体 |
CA3114859A1 (fr) | 2018-10-22 | 2020-04-30 | C4X Discovery Limited | Composes therapeutiques |
CN113461699B (zh) * | 2021-04-14 | 2022-06-21 | 宁波大学 | 一种四环吡咯生物碱类化合物及其制备方法和用途 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1165555B1 (fr) * | 1999-03-11 | 2003-07-16 | Neurogen Corporation | Pyridines 2,4-disubstituees fusionnees avec un aryle: ligands du recepteur nk-3 |
US20050070570A1 (en) * | 2003-06-18 | 2005-03-31 | 4Sc Ag | Novel potassium channels modulators |
EP1637529A1 (fr) * | 2004-09-20 | 2006-03-22 | 4Sc Ag | Nouveaux analogues de piperidin-4-yl-thiazole-carboxamide en tant qu'inhibiteurs de proliferation de lymphocytes T er leurs utilisations |
WO2007104557A2 (fr) * | 2006-03-15 | 2007-09-20 | 4Sc Ag | Nouveaux inhibiteurs hétérocycliques de nf/kb |
-
2008
- 2008-11-26 AU AU2008334075A patent/AU2008334075A1/en not_active Abandoned
- 2008-11-26 JP JP2010536184A patent/JP2011518109A/ja active Pending
- 2008-11-26 CN CN2008801260189A patent/CN102007101A/zh active Pending
- 2008-11-26 EP EP08857446A patent/EP2225207A2/fr not_active Withdrawn
- 2008-11-26 CA CA2707445A patent/CA2707445A1/fr not_active Abandoned
- 2008-11-26 WO PCT/US2008/084948 patent/WO2009073545A2/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CA2707445A1 (fr) | 2009-06-11 |
WO2009073545A2 (fr) | 2009-06-11 |
WO2009073545A3 (fr) | 2009-09-11 |
JP2011518109A (ja) | 2011-06-23 |
CN102007101A (zh) | 2011-04-06 |
EP2225207A2 (fr) | 2010-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2008334075A1 (en) | Tetrahydro-isoquinoline PPAT inhibitors as antibacterial agents | |
JP7111790B2 (ja) | イミダゾロニルキノリンおよびatmキナーゼ阻害剤としてのその使用 | |
US10493071B2 (en) | Use of pyrroloquinoline compounds to kill clinically latent microorganisms | |
EP2609082B1 (fr) | Imidazo[4,5-c]quinolines utilisés en tant qu'inhibiteurs d'adn-pk | |
JP5143000B2 (ja) | 抗感染症薬としての8−メトキシ−9H−イソチアゾロ[5,4−b]キノリン−3,4−ジオンおよび関連化合物 | |
EP2086542A1 (fr) | Formulations topiques | |
EP2588457B1 (fr) | Dérivés de pyrazoloquinoline en tant qu'inhibiteurs de dna-pk | |
US8124616B2 (en) | Bicyclic PPAT inhibitors as antibacterial agents | |
EP1628977B1 (fr) | DERIVES DE TETRAHYDRO-b-CARBOLINE ANTIBIOTIQUES | |
AU2008350293A1 (en) | Antibiotic tetrahydro-beta-carboline derivatives | |
US11992494B2 (en) | Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists | |
US20090203726A1 (en) | Substituted tetrahydroquinolines as antibacterial agents | |
WO2004064837A1 (fr) | Antibacterien inhibiteur du fab i |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1 | Application lapsed section 142(2)(a) - no request for examination in relevant period |